Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...

The outlook for end-stage COPD varies from person to person. Your outlook may depend on a number of factors, such as: Treatments for COPD can’t reverse damage that’s already been done ...

Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD) ...

If you are one of the millions of Americans living with COPD, you can breathe easier knowing that advances in treatments are helping people with your condition live a better quality of life.

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid ... with steroid drugs being the mainstay of medication. Steroids such as ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

The therapeutic goals of biologics remain the same as with other treatments for COPD, namely restoration of normal inflammatory response and alteration of disease progression, as well as ...

The medication segment was the largest in 2022, favored for its cost-effectiveness and common use as a first-line treatment. .Centriacinar Emphysema Growth: The centriacinar segment, primarily linked ...